Liberatore C, Ferretti VV, Tacchetti P, Conticello C, Barila G, Antonioli E, Belotti A, Cafro AM, Paris L, Bongarzoni V, Gentile M, Da Via M, Gamberi B, Pezzatti S, Ciambelli F, Garzia M, Annibali O, Fazio F, Antolino G, More S, Sgherza N, Farina F, Citro A, Steffanoni P, Del Fabro V, Cartia CS, Fioritoni F, Mancuso K, Attucci I, Pioltelli ML, Puppi M, Terlizzi S, Lisi C, Palumbo M, Offidani M, Petrucci MT, Mangiacavalli S. Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience. Haematologica; https://doi.org/10.3324/haematol.2025.289143 [Early view].